Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afentanil vs oxelidine vs sufentanil with etomidate + propofol for painless gastroscopy
ChiCTR2500098772Phase 4Not yet recruiting
- Sponsor
- Yanting County People's Hospital
- Start
- Mar 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alfentanil, oliceridine, sufentanil, etomidate and propofol in None (3 arms), sponsored by Yanting County People's Hospital. Primary endpoint: Incidence of respiratory depression. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
alfentaniloliceridinesufentaniletomidatepropofol
Beyond the preview
Go deeper on ChiCTR2500098772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098772.